Cargando…

Myelomatous Pleural Effusion: A Rare Involvement in Myeloma

Extramedullary disease (EMD) incidence is between 7% and 18% in multiple myeloma. Overall survival of patients who develop EMD is significantly shorter than that of patients without EMD. Malignant myelomatous pleural effusions (MPEs) are rarely observed, occurring in less than 1% of cases. The diagn...

Descripción completa

Detalles Bibliográficos
Autores principales: Alkan, Onur, Tiryaki, Tarik Onur, Kalayoglu-Besisik, Sevgi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8383523/
https://www.ncbi.nlm.nih.gov/pubmed/34434362
http://dx.doi.org/10.14740/jmc3428
_version_ 1783741755039940608
author Alkan, Onur
Tiryaki, Tarik Onur
Kalayoglu-Besisik, Sevgi
author_facet Alkan, Onur
Tiryaki, Tarik Onur
Kalayoglu-Besisik, Sevgi
author_sort Alkan, Onur
collection PubMed
description Extramedullary disease (EMD) incidence is between 7% and 18% in multiple myeloma. Overall survival of patients who develop EMD is significantly shorter than that of patients without EMD. Malignant myelomatous pleural effusions (MPEs) are rarely observed, occurring in less than 1% of cases. The diagnosis of MPE was confirmed by the detection of myeloma cells in the pleural fluid using flow cytometric analyses. We present a case of a 67-year-old male patient with IgG-kappa myelom. After a few line treatment regimens, he was admitted to hospital with back pain and blurred consciousness, and pleural effusion was detected. Pleural fluid analysis showed malignant plasma cells. It is a rare presentation of multiple myeloma, but important in diagnosis.
format Online
Article
Text
id pubmed-8383523
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elmer Press
record_format MEDLINE/PubMed
spelling pubmed-83835232021-08-24 Myelomatous Pleural Effusion: A Rare Involvement in Myeloma Alkan, Onur Tiryaki, Tarik Onur Kalayoglu-Besisik, Sevgi J Med Cases Case Report Extramedullary disease (EMD) incidence is between 7% and 18% in multiple myeloma. Overall survival of patients who develop EMD is significantly shorter than that of patients without EMD. Malignant myelomatous pleural effusions (MPEs) are rarely observed, occurring in less than 1% of cases. The diagnosis of MPE was confirmed by the detection of myeloma cells in the pleural fluid using flow cytometric analyses. We present a case of a 67-year-old male patient with IgG-kappa myelom. After a few line treatment regimens, he was admitted to hospital with back pain and blurred consciousness, and pleural effusion was detected. Pleural fluid analysis showed malignant plasma cells. It is a rare presentation of multiple myeloma, but important in diagnosis. Elmer Press 2020-03 2020-03-26 /pmc/articles/PMC8383523/ /pubmed/34434362 http://dx.doi.org/10.14740/jmc3428 Text en Copyright 2020, Alkan et al. https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Alkan, Onur
Tiryaki, Tarik Onur
Kalayoglu-Besisik, Sevgi
Myelomatous Pleural Effusion: A Rare Involvement in Myeloma
title Myelomatous Pleural Effusion: A Rare Involvement in Myeloma
title_full Myelomatous Pleural Effusion: A Rare Involvement in Myeloma
title_fullStr Myelomatous Pleural Effusion: A Rare Involvement in Myeloma
title_full_unstemmed Myelomatous Pleural Effusion: A Rare Involvement in Myeloma
title_short Myelomatous Pleural Effusion: A Rare Involvement in Myeloma
title_sort myelomatous pleural effusion: a rare involvement in myeloma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8383523/
https://www.ncbi.nlm.nih.gov/pubmed/34434362
http://dx.doi.org/10.14740/jmc3428
work_keys_str_mv AT alkanonur myelomatouspleuraleffusionarareinvolvementinmyeloma
AT tiryakitarikonur myelomatouspleuraleffusionarareinvolvementinmyeloma
AT kalayoglubesisiksevgi myelomatouspleuraleffusionarareinvolvementinmyeloma